Dr. Boada is a distinguished professor at the International University of Catalonia, member of the Executive Committee of the EADC (European Alzheimer’s Disease Consortium) and principal investigator of the Ace Group of CIBERNED (Biomedical Research Center of the Network of Neurodegenerative Diseases, Carlos III Institute, Madrid).

She completed her professional training in the Neurology Service of the Vall d’Hebrón University Hospital, in Barcelona. She held the position of Chief Clínic, being responsible for the research area in dementia and Alzheimer’s of the Vall d’Hebrón Research Institute. She was secretary of the Generalitat de Catalunya, technician of the Advisory Council on Psychogeriatrics of the Catalan Health Service, which developed the Dementia Plan (Specific Policies for the detection and attention of cognitive and behavioral disorders. 1998).

At the European level, she has led the MOPEAD project (Models of Patient Engagement for Alzheimer’s Disease), has jointly led the ADAPTED project (Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development) with Dr. Agustín Ruíz, both funded by the European Union through the IMI (Innovative Medicines Initiative) and EFPIA (European Federation of Pharmaceutical Industries and Associations).

She has also participated as a researcher in the projects EPAD (European Prevention of Alzheimer’s Dementia Consortium), AMYPAD (Amyloid Imaging to Prevent Alzheimer’s Disease), PreDADQoL (Ethical and legal framework for Predictive Diagnosis of Alzheimer’s Disease: Quality of Life of individual at risk) and PreTAD (The Predictive Turn in Alzheimer’s Disease: Ethical, Clinical, Linguistic, and Legal Aspects).

She is a principal researcher and co-investigator in several genetic projects: GR@ACE (Genomic Research in Ace), from the FACEHBI cohort (Ace Healthy Brain Initiative) and NORFACE (Research in Ace Neuroophthalmology) and TARTAGLIA.

At the institutional level, he has directed more than 135 international clinical trials on Alzheimer’s and other dementias. She has been a consultant and collaborator of the pharmaceutical industry in different studies on Alzheimer’s disease.

She has published 557 scientific papers (Research Gate; h-index: 67), 37 book chapters and 12 books on popular medicine.

In terms of ethical-social research, she is co-editor of the SITGES Document 2005 and 2009 of the Spanish Society of Neurology.

Member of the Board of Trustees of the Catalunya La Pedrera Foundation and promoter of its REMS program (Reinforce and stimulate memory and health).

For more information: https://orcid.org/0000-0003-2617-3009